Skip to main content
. 2025 May 17;24:181. doi: 10.1186/s12944-025-02599-2

Table 3.

Association of ABSI and PEF/PEF prediction (Multiple imputation)

Categories Model 1 Model 2 Model 3 Model 4
β(95%CI) P value β(95%CI) P value β(95%CI) P value β(95%CI) P value
All ABSI** −2.08 (−2.78 ~ −1.38)  < 0.001 −3.12 (−3.98 ~ −2.27)  < 0.001 −3.16 (−4.13 ~ −2.20)  < 0.001 −3.16 (−4.21 ~ −2.10)  < 0.001
ABSI** Quintile
Q1 (1.70 ~ 6.86) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref)
Q2 (6.86 ~ 7.18) −0.49 (−1.87 ~ 0.89) 0.486 −0.61 (−2.03 ~ 0.82) 0.403 −0.50 (−2.10 ~ 1.09) 0.537 −0.30 (−2.02 ~ 1.43) 0.734
Q3 (7.18 ~ 7.46) −0.63 (−2.01 ~ 0.75) 0.368 −2.33 (−3.83 ~ −0.83) 0.002 −1.83 (−3.51 ~ −0.15) 0.033 −1.70 (−3.52 ~ 0.12) 0.068
Q4 (7.46 ~ 7.76) 0.23 (−1.15 ~ 1.61) 0.739 −2.64 (−4.26 ~ −1.02) 0.001 −2.36 (−4.17 ~ −0.54) 0.011 −2.90 (−4.88 ~ −0.91) 0.004
Q5 (7.76 ~ 11.40) −3.63 (−5.01 ~ −2.25)  < 0.001 −6.06 (−7.79 ~ −4.33)  < 0.001 −5.84 (−7.78 ~ −3.90)  < 0.001 −5.81 (−7.95 ~ −3.67)  < 0.001
P for trend  < 0.001  < 0.001  < 0.001  < 0.001
Male
ABSI** −4.01 (−5.30 ~ −2.71)  < 0.001 −3.35 (−4.73 ~ −1.96)  < 0.001 −3.25 (−4.83 ~ −1.67)  < 0.001 −3.30 (−5.05 ~ −1.55)  < 0.001
ABSI** Quintile
Q1 (2.31 ~ 7.29) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref)
Q2 (7.29 ~ 7.51) 1.77 (−0.32 ~ 3.85) 0.097 1.46 (−0.70 ~ 3.63) 0.186 1.35 (−1.14 ~ 3.84) 0.287 1.07 (−1.62 ~ 3.76) 0.436
Q3 (7.51 ~ 7.71) 1.03 (−1.06 ~ 3.12) 0.333 0.94 (−1.23 ~ 3.10) 0.396 0.74 (−1.74 ~ 3.22) 0.561 −0.32 (−3.04 ~ 2.41) 0.819
Q4 (7.71 ~ 7.93) 0.71 (−1.38 ~ 2.79) 0.506 0.38 (−1.80 ~ 2.56) 0.733 −0.34 (−2.85 ~ 2.17) 0.789 −0.98 (−3.75 ~ 1.78) 0.486
Q5 (7.93 ~ 11.40) −4.50 (−6.59 ~ −2.41)  < 0.001 −3.72 (−5.96 ~ −1.47) 0.001 −3.10 (−5.63 ~ −0.57) 0.016 −3.86 (−6.69 ~ −1.03) 0.008
P for trend  < 0.001 0.002 0.008 0.003
Female
ABSI** −3.84 (−4.82 ~ −2.86)  < 0.001 −3.01 (−4.08 ~ −1.93)  < 0.001 −3.10 (−4.31 ~ −1.89)  < 0.001 −3.12 (−4.42 ~ −1.82)  < 0.001
ABSI** Quintile
Q1 (1.70 ~ 6.67) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref)
Q2 (6.67 ~ 6.92) 0.45 (−1.37 ~ 2.26) 0.630 0.56 (−1.30 ~ 2.41) 0.556 0.29 (−1.80 ~ 2.39) 0.783 −0.09 (−2.34 ~ 2.15) 0.937
Q3 (6.92 ~ 7.13) −1.39 (−3.20 ~ 0.43) 0.134 −0.74 (−2.60 ~ 1.12) 0.435 −0.44 (−2.53 ~ 1.64) 0.678 −0.24 (−2.49 ~ 2.01) 0.837
Q4 (7.13 ~ 7.40) −2.42 (−4.24 ~ −0.61) 0.009 −2.47 (−4.37 ~ −0.57) 0.011 −1.72 (−3.83 ~ 0.40) 0.112 −1.98 (−4.28 ~ 0.31) 0.091
Q5 (7.40 ~ 10.0) −7.03 (−8.85 ~ −5.22)  < 0.001 −6.14 (−8.15 ~ −4.12)  < 0.001 −5.43 (−7.66 ~ −3.19)  < 0.001 −5.53 (−7.97 ~ −3.09)  < 0.001
P for trend  < 0.001  < 0.001  < 0.001  < 0.001

ABSI a body shape index, PEF peak expiratory flow, PEF/PEF prediction ratio of peak expiratory flow to predicted peak expiratory flow, TC total cholesterol, TG triglycerides, LDL low-density lipoprotein, β coefficient, CI confidence interval

Model 1: not adjusted

Model 2: adjusted for age, race, residence, educational status, marital status, sleep duration(total population adjusted for sex)

Model 3: adjusted for model 2, additionally adjusted for smoking status, drinking status, hypertension, diabetes, heart diseases, stroke, dyslipidemias, kidney diseases

Model 4: adjusted for model 3, additionally adjusted for creatinine, glucose, TC, TG, LDL, Cystatin C

**Continuous variable: ABSI was scaled by a factor of 100